Spotlight
Video

Patient Reported Outcomes Measure Tolerabilty | Trial Showed Benefits for Regimen Over Sunitinib

Loading........
Description: Brian I. Rini, MD, Cleveland Clinic shares Patient Reported Outcomes Measure Tolerabilty | Trial Showed Benefits for Regimen Over Sunitinib at Annual Meeting 2018
Shared By : Annual-Meeting
Posted on : 06/21/18
Added : 1 year ago
Category : Kidney Cancer



Recommended

Nothing found.